Company Filing History:
Years Active: 2024
Title: Miriam Moheysen-Zadeh: Innovator in Anti-Drug Antibody Assays
Introduction
Miriam Moheysen-Zadeh is a notable inventor based in Germany. She has made significant contributions to the field of immunoassays, particularly in the quantification of anti-drug antibodies. Her work is essential for improving therapeutic outcomes in patients receiving drug treatments.
Latest Patents
Miriam Moheysen-Zadeh holds a patent titled "Target Interference Suppressed Anti-Drug Antibody Assay." This innovative immunoassay is designed to quantify the amount of anti-drug antibody that can specifically bind to a drug antibody, which in turn binds to a therapeutic target. The assay involves several steps, including incubating serum or plasma samples at specific pH values, adjusting conditions to form complexes, and quantifying these complexes to determine the amount of anti-drug antibody present.
Career Highlights
Miriam is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. Her role involves developing advanced immunoassay techniques that enhance the accuracy and reliability of drug monitoring in clinical settings. Despite having no patents to her name, her contributions to the field are invaluable.
Collaborations
Miriam has collaborated with esteemed colleagues such as Uwe Dahl and Gregor Jordan. These partnerships have fostered innovation and have been instrumental in advancing research in the field of immunoassays.
Conclusion
Miriam Moheysen-Zadeh is a pioneering inventor whose work in anti-drug antibody assays is shaping the future of therapeutic monitoring. Her dedication to innovation continues to impact the healthcare industry positively.